122323-88-0 Usage
Uses
Used in Pharmaceutical Synthesis:
Piperazine-2-carboxylic acid methyl ester dihydrochloride is used as a key intermediate for the production of various pharmaceuticals. Its reactivity and properties allow for the creation of a wide range of medications, contributing to the advancement of healthcare.
Used in Organic Synthesis:
As a reagent in organic synthesis, Piperazine-2-carboxylic acid methyl ester dihydrochloride is utilized for its ability to facilitate chemical reactions, leading to the formation of desired products in the synthesis of organic compounds.
Used in Drug Development:
Piperazine-2-carboxylic acid methyl ester dihydrochloride is used as a prodrug, which means it is metabolized in the body to release the active pharmaceutical agent. This application is particularly important in the development of new drugs, as it allows for the design of medications that can be more easily absorbed and utilized by the body.
Used in the Chemical Industry:
Due to its versatile properties, Piperazine-2-carboxylic acid methyl ester dihydrochloride finds applications in the chemical industry for various purposes, including the synthesis of other chemical compounds and materials. Its reactivity makes it a useful component in a range of chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 122323-88-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,3,2 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 122323-88:
(8*1)+(7*2)+(6*2)+(5*3)+(4*2)+(3*3)+(2*8)+(1*8)=90
90 % 10 = 0
So 122323-88-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H12N2O2.2ClH/c1-10-6(9)5-4-7-2-3-8-5;;/h5,7-8H,2-4H2,1H3;2*1H
122323-88-0Relevant articles and documents
KRAS G12C INHIBITORS
-
Paragraph 0247, (2020/07/25)
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors
-
, (2011/04/24)
The present invention provides methods of treating aneurysmal dilatation, blood vessel wall weakness, and specifically abdominal aortic aneurysm and thoracic aneurysm by inhibiting MMPs and ADAM-10. Such compounds are useful in the in vitro study of the r
SYNTHESIS AND CONVERSIONS OF PIPERAZINE-2-CARBOXYLIC ACID
Kutina, N. N.,Zhikhareva, G. P.,Anisimova, O. S.,Yakhontov, L. N.
, p. 693 - 696 (2007/10/02)
A method has been developed for the synthesis of methyl piperazinium-2-carboxylate dihydrochloride (overall yield 46percent) and piperazinium-2-carboxylic acid dihydrochloride (overall yield 36percent), from ethylene diamine through N,N'-di(trifluoroacetyl)ethylenediamine and methyl N,N'-di(trifluoroacetyl)piperazine-2-carboxylate.The N,N'-dinitroso derivatives were synthesized.
